Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00005641
What this trial is testing

Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+2 more
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Ended earlyNCT00675441
What this trial is testing

Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)

Who this might be right for
Graft-versus-Host Disease
M.D. Anderson Cancer Center 5
Post-approval studies (Phase 4)Study completedNCT02342145
What this trial is testing

Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major

Who this might be right for
Beta-Thalassemia MajorGraft-versus-host Disease (GVHD)
Zhongming Zhang 205
Testing effectiveness (Phase 2)Study completedNCT00141739
What this trial is testing

Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Graft-Versus-Host Disease
University of Michigan Rogel Cancer Center 100
Not applicableNot Yet RecruitingNCT07440654
What this trial is testing

Efficacy and Safety of Gecacitinib Hydrochloride in Prophylaxis Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis

Who this might be right for
aGVHD Prophylaxis
Nanfang Hospital, Southern Medical University 40
Early research (Phase 1)Ended earlyNCT02231710
What this trial is testing

Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases

Who this might be right for
Primary Immune Deficiency DisordersHemophagocytic LymphohistiocytosisInherited Bone Marrow Failure Syndrome+2 more
Bellicum Pharmaceuticals 1
Early research (Phase 1)Study completedNCT03207958
What this trial is testing

Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Vs Host DiseaseGraft-versus-host-disease
Washington University School of Medicine 10
Not applicableStudy completedNCT02064972
What this trial is testing

CEC Count Changes to Support GvHD Diagnosis.

Who this might be right for
Graft vs Host DiseaseComplications of Organ Transplant Stem CellsEndothelial Dysfunction
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 50
Not applicableUnknownNCT00912067
What this trial is testing

Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in Adults

Who this might be right for
Graft Versus Host Disease
Sheba Medical Center 120
Large-scale testing (Phase 3)Study completedNCT01699412
What this trial is testing

Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host Disease

Who this might be right for
Graft vs Host DiseaseOral Manifestations
Grupo de Estudos Multicentricos em Onco-Hematologia 28
Early research (Phase 1)Looking for participantsNCT06462365
What this trial is testing

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Who this might be right for
Hematologic MalignancyGvHDGVHD,Acute+8 more
Tr1X, Inc. 36
Testing effectiveness (Phase 2)Looking for participantsNCT05289167
What this trial is testing

Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)

Who this might be right for
Graft-versus-host Disease
Northwell Health 74
Testing effectiveness (Phase 2)Study completedNCT02065154
What this trial is testing

Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndrome+3 more
University of Alabama at Birmingham 39
Testing effectiveness (Phase 2)Study completedNCT02759731
What this trial is testing

Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Chronic Graft vs Host DiseaseChronic Graft-Versus-Host Disease
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT01390402
What this trial is testing

Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG

Who this might be right for
LeukemiaChronic Myelogenous Leukemia
M.D. Anderson Cancer Center 6
Not applicableNot Yet RecruitingNCT06386445
What this trial is testing

Study on the Serum Metabolic Markers and Early Complications After Allo-HSCT： Cohort Study

Who this might be right for
Stem Cell Transplant ComplicationsAcute Graft Versus Host DiseaseAcute Kidney Injury+1 more
First Affiliated Hospital Xi'an Jiaotong University 500
Not applicableUnknownNCT00563589
What this trial is testing

Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell Transplantation

Who this might be right for
Graft vs Host DiseaseHematopoietic Stem Cell Transplantation
Hospital Authority, Hong Kong 30
Large-scale testing (Phase 3)Study completedNCT00755040
What this trial is testing

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Vanderbilt-Ingram Cancer Center 164
Not applicableLooking for participantsNCT07205523
What this trial is testing

High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)

Who this might be right for
Hematopoietic Stem Cell Transplantation (HSCT)Acute Myeloid Leukemia (AML)Leukemias, Acute Myeloid+12 more
Yigeng Cao,MD,PhD 1,000
Not applicableUnknownNCT00587574
What this trial is testing

Prospective Phase II Study for Assessment of Regulatory Immune Cell Populations After Allogeneic HSCT

Who this might be right for
Allogeneic Hematopoietic Cell Transplant Recipients
Medical University of Vienna 150
Next Page